Search for: "ACTAVIS" Results 181 - 200 of 1,004
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2013, 8:50 pm by Patent Docs
.; Actavis Elizabeth LLC; Actavis Inc. [read post]
5 Apr 2015, 9:59 pm by Patent Docs
.; Actavis Inc.; Actavis plc Infringement of U.S. [read post]
20 Apr 2017, 9:58 pm by Patent Docs
Actavis Laboratories FL, Inc. et al. v Janssen Oncology, Inc. [read post]
17 Nov 2013, 8:56 pm by Patent Docs
• Defendants: Watson Laboratories Inc; Actavis, Inc.; Actavis Pharma, Inc. [read post]
5 Nov 2015, 9:39 pm by Patent Docs
Laboratories Inc.; Grunenthal GmbH • Defendant: Actavis Laboratories FL, Inc. [read post]
29 Jul 2014, 9:11 pm by Patent Docs
Actavis Laboratories FL Inc. 1:14-cv-00882; filed July 7, 2014 in the District Court of Delaware Infringement of U.S. [read post]
31 Aug 2014, 9:05 pm by Patent Docs
.; Actavis Inc.; Actavis LLC Infringement of U.S. [read post]
30 Aug 2019, 4:15 am by Dustin Weeks
The Federal Circuit recently affirmed in part and reversed in part a district court decision holding that Actavis Laboratories FL, Inc. [read post]
17 Jun 2013, 7:44 am by Kali Borkoski
This case is an antitrust challenge to an increasingly common practice in the pharmaceutical industry. [read post]
8 Jun 2015, 12:22 am
 Warner-Lambert sued, because they considered that the Actavis product was still likely to be prescribed for the patented indication and that Actavis was liable for such sales.In a first judgment, Arnold J denied interim relief to Warner-Lambert, holding that a Swiss form claim required subjective intent on the part of Actavis that the drug would be used for the treatment of pain, that Warner-Lambert had no pleaded case on subjective intent, and that therefore there… [read post]
10 Aug 2010, 10:50 pm by Carey, Danis & Lowe, L.L.C.
Austin is filing complaint against three companies, specifically Actavis, Actavis Elizabeth and Watson Pharmaceuticals. [read post]
10 Feb 2014, 2:48 am by Lawrence B. Ebert
Actavis, “pay for delay” means money relevant to a possible appeal of In re: Lamictal, No. 12-cv-995, 2012 WL 6725580 (D.N.J. [read post]
19 Jun 2013, 4:01 pm by Kprofs2013
Actavis that permitted the Federal Trade Commission to sue pharmaceutical companies for potential antitrust violations when they enter into “pay-to-delay” agreements. [read post]
20 Jun 2013, 1:00 am by Courtenay Brinckerhoff
Actavis, Inc., the Supreme Court held that reverse payment (“pay-for-delay”) settlement agreements made in the context of settling Hatch-Waxman ANDA litigation should be evaluated for antitrust violations under a “rule of reason” analysis. [read post]
16 Aug 2013, 12:39 pm by HealthLawProf Hodnicki
Hovenkamp, Anticompetitive Patent Settlements and the Supreme Court's Actavis Decision, 15 Minn. [read post]